Real-world experience of ozanimod in adults with multiple sclerosis.

Cooperrider J, Lambe J, Chu M, Du M, Reardon J, Chaudry B, Thorpe A, Hersh CM, Conway D.

DOI: 10.1080/17582024.2026.2622078
Published: 2026-01-29
Container: Neurodegener Dis Manag
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17582024.2026.2622078,
  title = {Real-world experience of ozanimod in adults with multiple sclerosis.},
  author = {Cooperrider J and  Lambe J and  Chu M and  Du M and  Reardon J and  Chaudry B and  Thorpe A and  Hersh CM and  Conway D.},
  year = {2026},
  journal = {Neurodegener Dis Manag},
  doi = {10.1080/17582024.2026.2622078},
  url = {https://doi.org/10.1080/17582024.2026.2622078}
}

RIS

TY  - JOUR
TI  - Real-world experience of ozanimod in adults with multiple sclerosis.
AU  - Cooperrider J
AU  -  Lambe J
AU  -  Chu M
AU  -  Du M
AU  -  Reardon J
AU  -  Chaudry B
AU  -  Thorpe A
AU  -  Hersh CM
AU  -  Conway D.
PY  - 2026
JO  - Neurodegener Dis Manag
DO  - 10.1080/17582024.2026.2622078
UR  - https://doi.org/10.1080/17582024.2026.2622078
ER  -

APA

J, C., J, L., M, C., M, D., J, R., B, C., A, T., CM, H., & D., C. (2026). Real-world experience of ozanimod in adults with multiple sclerosis.. Neurodegener Dis Manag. https://doi.org/10.1080/17582024.2026.2622078

Source records

europe-pmc · retrieved 2026-09-26T05:48:42.431Z